Can a novel measure of acute bronchodilator responsiveness predict improvement in exercise capacity after four weeks treatment with tiotropium bromide in subjects with chronic obstructive pulmonary disease?

Trial Profile

Can a novel measure of acute bronchodilator responsiveness predict improvement in exercise capacity after four weeks treatment with tiotropium bromide in subjects with chronic obstructive pulmonary disease?

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs Salbutamol (Primary) ; Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top